Back to Authors

Seeley, William W.

https://orcid.org/0000-0003-1410-2027

A5074694043 | I180670191

Mayo Clinic

University of California, San Francisco

Citations 71

Alzheimer's Disease–Related Dementias Summit 2016: National research priorities

Neurology | November 8, 2017 | Volume: 89 | Issue: 23 | Pages: 2381-2391

10.1212/wnl.0000000000004717 | PMID 29117955

Transethnic genome‐wide scan identifies novel Alzheimer's disease loci

Alzheimer's & Dementia | February 6, 2017 | Volume: 13 | Issue: 7 | Pages: 727-738

10.1016/j.jalz.2016.12.012 | PMID 28183528

Abstract Introduction Genetic loci for Alzheimer's disease (AD) have been identified in whites of European ancestry, but the genetic architecture of AD among other populations is less understood. Methods We conducted a transethnic genome‐wide association study (GWAS) for late‐onset AD in Stage 1 sample including whites of European Ancestry, African‐Americans, Japanese, and Israeli‐Arabs assembled by the Alzheimer's Disease Genetics Consortium. Suggestive results from Stage 1 from novel loci were followed up using summarized results in the International Genomics Alzheimer's Project GWAS dataset. Results Genome‐wide significant (GWS) associations in single‐nucleotide polymorphism (SNP)–based tests ( P < 5 × 10 −8 ) were identified for SNPs in PFDN1/HBEGF , USP6NL/ECHDC3 , and BZRAP1‐AS1 and for the interaction of the (apolipoprotein E) APOE ε4 allele with NFIC SNP. We also obtained GWS evidence ( P < 2.7 × 10 −6 ) for gene‐based association in the total sample with a novel locus, TPBG ( P = 1.8 × 10 −6 ). Discussion Our findings highlight the value of transethnic studies for identifying novel AD susceptibility loci.
Frontotemporal dementia with the V337M MAPT mutation

Neurology | January 27, 2017 | Volume: 88 | Issue: 8 | Pages: 758-766

10.1212/wnl.0000000000003636 | PMID 28130473

Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts

Neurology Neuroimmunology & Neuroinflammation | October 29, 2016 | Volume: 3 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000000301 | PMID 27844039

Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States

JAMA Neurology | December 22, 2014 | Volume: 72 | Issue: 2 | Pages: 209

10.1001/jamaneurol.2014.2157 | PMID 25531812

Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease

JAMA Neurology | September 8, 2014 | Volume: 71 | Issue: 11 | Pages: 1394

10.1001/jamaneurol.2014.1491 | PMID 25199842

Recommendations of the Alzheimer's Disease–Related Dementias Conference

Neurology | July 31, 2014 | Volume: 83 | Issue: 9 | Pages: 851-860

10.1212/wnl.0000000000000733 | PMID 25080517

Neurodegeneration, Königsberg, and the New York City subway

Neurology | May 30, 2013 | Volume: 81 | Issue: 2 | Pages: 104-106

10.1212/wnl.0b013e31829a3553 | PMID 23719146

Frontotemporal dementia due toC9ORF72mutations

Neurology | August 9, 2012 | Volume: 79 | Issue: 10 | Pages: 1002-1011

10.1212/wnl.0b013e318268452e | PMID 22875087

P4‐166: Determinants of survival in autopsy‐confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC)

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_22 | Pages: No page available

10.1016/j.jalz.2011.05.2188